UBS Group
GNLX icon

UBS Group’s Genelux GNLX Stock Holding History

UBS Group’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Sell
34,995
-87,584
-71% -$248K ﹤0.01% 7162
2026
Q1 		$297K Buy
122,579
+75,219
+159% +$205K ﹤0.01% 6413
2025
Q4 		$206K Buy
47,360
+19,581
+70% +$106K ﹤0.01% 6560
2025
Q3 		$117K Sell
27,779
-43,445
-61% -$154K ﹤0.01% 7011
2025
Q2 		$204K Buy
71,224
+3,088
+5% +$8.16K ﹤0.01% 6707
2025
Q1 		$184K Buy
68,136
+43,045
+172% +$161K ﹤0.01% 6609
2024
Q4 		$59.2K Sell
25,091
-14,998
-37% -$39.9K ﹤0.01% 7190
2024
Q3 		$95K Buy
40,089
+8,457
+27% +$18.6K ﹤0.01% 6411
2024
Q2 		$61.7K Sell
31,632
-12,484
-28% -$42.4K ﹤0.01% 6527
2024
Q1 		$284K Buy
44,116
+23,786
+117% +$216K ﹤0.01% 5607
2023
Q4 		$285K Buy
20,330
+10,305
+103% +$163K ﹤0.01% 5537
2023
Q3 		$246K Buy
10,025
+7,008
+232% +$178K ﹤0.01% 5217
2023
Q2 		$98.7K Buy
3,017
+2,833
+1,540% +$79.7K ﹤0.01% 6026
2023
Q1 		$5.1K Buy
+184
New +$2.98K ﹤0.01% 8086

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

UBS Group's GNLX Position: Q2 2026 in Review

UBS Group reduced its Genelux (GNLX) stake by 71% in Q2 2026, selling an estimated $248K and leaving 34,995 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #7162.

UBS Group first reported a position in GNLX in Q1 2023 and has held it in 14 quarters since. The position peaked at $297K in Q1 2026. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • UBS Group held 34,995 shares of Genelux worth $105K as of Q2 2026.
  • UBS Group sold 87,584 Genelux shares in Q2 2026, an estimated $248K.
  • Genelux made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7162 holding.
  • UBS Group first reported a position in Genelux in Q1 2023 and has held it in 14 quarters since.
  • UBS Group's Genelux position peaked at $297K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.